Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $3.62 Million - $4.11 Million
-34,000 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $214,830 - $236,502
-2,100 Reduced 5.82%
34,000 $3.68 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $438,141 - $514,233
-5,100 Reduced 12.38%
36,100 $3.16 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $968,484 - $1.3 Million
13,200 Added 47.14%
41,200 $4.05 Million
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $258,000 - $391,160
4,000 Added 16.67%
28,000 $2.13 Million
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $1.73 Million - $2.17 Million
24,000 New
24,000 $2.13 Million
Q2 2019

Aug 09, 2019

SELL
$65.7 - $83.98 $3.43 Million - $4.38 Million
-52,200 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $7.81 Million - $9.19 Million
-101,200 Reduced 65.97%
52,200 $4.21 Million
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $6.69 Million - $8.25 Million
-85,900 Reduced 35.9%
153,400 $14.1 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $177,820 - $197,680
2,000 Added 0.84%
239,300 $22.6 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $5.66 Million - $6.69 Million
63,000 Added 36.14%
237,300 $22 Million
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $2.85 Million - $3.82 Million
31,000 Added 21.63%
174,300 $16.5 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $10 Million - $12.8 Million
143,300
143,300 $12.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Origin Asset Management LLP Portfolio

Follow Origin Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Origin Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Origin Asset Management LLP with notifications on news.